Trifluoroacetylation of N-Substituted 1H-1,2-Diazaphenalenes of the Naphthalene and Acenaphthene Series
作者:N. I. Omelichkin、L. G. Minyaeva、M. S. Korobov、G. S. Borodkin、L. G. Kuz’mina、V. V. Mezheritskii
DOI:10.1134/s107042801901010x
日期:2019.1
The acylation of N-substituted 3-methyl-1H-1,2-diazaphenalenes of the naphthalene and acenaphthene series with trifluoroacetic anhydride gave mono- and diacylated products. Despite the presence of a bulky substituent on the pyrrole type nitrogen atom, the trifluoroacetyl group entered the peri position with respect to that substituent. The product structure was confirmed by X-ray analysis.
用三氟乙酸酐对萘和系列的N-取代的3-甲基-1 H -1,2-二氮杂苯二甲酰基进行酰化,得到单和二酰化的产物。尽管在吡咯型氮原子上存在庞大的取代基,但三氟乙酰基仍相对于该取代基进入周边位置。通过X射线分析确认了产物结构。
Structure of the trifluoroacetylation product of 1-ethyl-6-methoxy-3-methyl-1H-1,2-diazaphenalene
作者:N. I. Omelichkin、L. G. Kuz’mina、L. G. Minyaeva、V. V. Mezheritskii
DOI:10.1134/s1070428017030319
日期:2017.3
1-Ethyl-6-methoxy-3-methyl-1H-1,2-diazaphenalene was readily acylated with trifluoroacetic anhydride with formation of 1-ethyl-6-methoxy-3-methyl-7,9-bis(trifluoroacetyl)-1H-1,2-diazaphenalene.
Non-Peptidic Inhibitors of AKAP/PKA Interaction
申请人:Klussmann Enno
公开号:US20090176773A1
公开(公告)日:2009-07-09
The invention relates to non-peptidic molecules which modulate, especially inhibit, the interaction of protein kinase A (PKA) and A kinase anchor proteins (AKAP) and to a host or target organism that comprises said non-peptidic compounds or recognition molecules directed to said compounds, such as e.g. antibodies or chelating agents. The invention also relates to a pharmaceutical agent, especially for use in the treatment of diseases that are associated with a disturbance of the cAMP signal path, especially insipid diabetes, hypertonia, pancreatic diabetes, duodenal ulcer, asthma, heart failure, obesity, AIDS, edema, hepatic cirrhosis, schizophrenia and others. The invention also relates to the use of the inventive molecules.